Abstract
Corticotropin releasing factor (CRF) is a key hormone in the integrated response to stress, acting both as the major regulator of pituitary adrenocorticotropic hormone (ACTH) release and as a neuropeptide in the brain1,2. The actions of CRF are mediated by specific plasma membrane receptors in the anterior pituitary gland3 and in discrete brain areas including the cerebral cortex and several regions related to the limbic system4,5. In addition to the pituitary and central actions of CRF, systemic administration of the peptide in the rat6, dog7,8, monkey9 and man10–12 causes hypotension and tachycardia because of a decrease in peripheral vascular resistance. These observations, in conjunction with the finding of immunoreactive13–17 and bioactive14,18 CRF in peripheral tissues, suggest that the peptide is locally released in tissues to act as a neurotransmitter or paracrine hormone. As CRF is present in the adrenal medulla13,14 and the peptide is known to modulate the central activity of the autonomie nervous system1, we investigated the possibility that CRF is involved in the regulation of the peripheral autonomie nervous system. Such an action of CRF is supported by our demonstration of specific CRF receptors in the monkey adrenal medulla and sympathetic ganglia. In the adrenal medulla, these receptors are coupled to adenylate cyclase and can stimulate the secretion of catecholamines and Met-enkephalin.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vale, W., Spiess, J., Rivier, C. & Rivier, J. Science 213, 1394–1397 (1981).
Aguilera, G. et al. J. Neuroendocr. (in the press).
Wynn, P. C., Aguilera, G., Morell, J. & Catt, K. J. Biochem. biophys. Res. Commun. 110, 602–609 (1983).
Wynn, P. C. et al. Peptides 5, 1077–1084 (1984).
De Souza, E. B. et al. Science 224, 1449–1450 (1984).
Fisher, L. A., Brown, M. R. in Current Topics in Neuroendocrinology (eds Ganten, D. & Pfaff, D) 87 (Springer, Berlin, 1983).
MacCannell, K. L., Lederis, K., Hamilton, P. L. & Rivier, J. Pharmacology 25, 116–120 (1982).
Brown, M. R. et al. Regulat. Peptides 4, 107–114 (1982).
Udelsman, R. et al. in The Adrenal Gland and Hypertension (eds Mantero, F. & Biglieri, E.) (Raven, New York, in the press).
Orth, D. N. et al. J. clin. Invest. 71, 587–595 (1983).
Hermus, A. et al. Lancet, i, 776(1983).
Schurmeyer, T. H. et al. J. clin, endocr. Metab. 59, 1103–1108 (1984).
Suda, T. et al. J. clin. endocr. Metab. 58, 919–924 (1984).
Hashimoto, K. et al. Peptides 5, 707–711 (1984).
De Cherney, G. S., Nicholson, W. E., Jackson, R. V. & Orth, D. N. Clin. Res. 32, 264A (1984).
Petrusz, P., Merchenthaler, I., Maderdrut, J. L., Vigh, S. & Schally, A. V. Proc. natn. Acad. Sci. U.S.A. 80, 1721–1725 (1983).
Nieuwenhuijzen Kruseman, A. C., Linton, E. A., Lowry, P. J., Rees, L. H. & Besser, G. M. Lancet ii, 1245–1246 (1982).
Carey, R. M. et al. New Engl. J. Med. 311, 13–20 (1984).
Schurmeyer, T. H. et al. Endocrinology 117, 300–302 (1985).
Vale, W. et al. Endocrinology 113, 1121–1131 (1983).
Aguilera, G. et al. J. biol. Chem. 258, 8039–8045 (1983).
Mukherjee, C., Caron, M. C. & Lefkowitz, R. J. Endocrinology 99, 347–357 (1976).
Lin, M. C., Lin, C.-S. & Whitlock, J. P. J. biol. Chem. 254, 4684–4688 (1979).
Harwood, J. P., Reichert, N. D., Dufau, M. L. & Catt, K. J. Endocrinology 106, 280–288 (1980).
Corder, R. et al. Neuropeptides 3, 9–17 (1982).
Eiden, L. E., Eskay, R. L., Scott, J., Pollard, H. & Hotchkiss, A. J. Life Sci. 33, 687–693 (1983).
Evans, C. J., Erdelyi, E., Weber, E. & Barchas, J. D. Science 221, 957–960 (1983).
Berenyi, M. R., Singh, G., Gloster, E. S., Davidson, M. I., Woldenberg, D. H. Archs Path. 101, 31–35 (1977).
Wilson, S. P., Chang, K. J. & Viveros, O. H. J. Neurosci. 2, 1150–1156 (1982).
Eiden, L. E. & Hotchkiss, A. J. Neuropeptides 4, 1–9 (1983).
Quack, T. T. et al. Molec. Pharmac. 26, 255–260 (1984).
Seamon, K. B., Padgett, W. & Daly, J. W. Proc. natn. Acad. Sci. U.S.A. 78, 3363–3367 (1981).
Sjostrand, T. Skand. Archs Physiol. 71, 85–122 (1934).
Hamaji, M. & Harrison, T. S. in Blood Vessels and Lymphatics in Organ Systems (eds Abramson, D. I. & Dobrin, P. B.) 280–295 (Academic, New York, 1984).
Ketelslegers, J. M., Knott, G. D. & Catt, K. J. Biochemistry 14, 3075–3083 (1975).
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. J. biol. Chem. 193, 265–275 (1951).
Quirion, R., Hammer, R. P., Herkenman, M. & Pert, C. Proc. natn. Acad. Sci. U.S.A. 78, 5581–5585 (1981).
Duncan, D. B. Biometrics 11, 1–42 (1955).
Greenberg, A. & Zinder, O. Cell Tissue Res. 226, 655–656 (1982).
Goldstein, D. S., Feuerstein, G., Izzo, J. L. Jr, Kopin, I. J. & Keiser, H. R. Life Sci. 28, 467–475 (1981).
Miller, R. J., Chang, K. J., Cooper, B. & Cuatrecasas, P. J. biol. Chem. 253, 531–538 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Udelsman, R., Harwood, J., Millan, M. et al. Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system. Nature 319, 147–150 (1986). https://doi.org/10.1038/319147a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/319147a0
This article is cited by
-
Acute iv CRH administration significantly increases serum active ghrelin in postmenopausal PCOS women compared to postmenopausal controls
Endocrine (2023)
-
Gene Expression of Phenylethanolamine N-Methyltransferase in Corticotropin-Releasing Hormone Knockout Mice During Stress Exposure
Cellular and Molecular Neurobiology (2006)
-
The emerging role of peripheral corticotropin-releasing hormone (CRH)
Journal of Endocrinological Investigation (2003)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.